Lindsay Hayler, PA
Physician Assistant · Manchester, TNNPI 1053558023
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,090 of the $36,456 with a category attached, or 77.1%. Galderma Laboratories, L.p. accounts for 94.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $25,270 and has fallen 93.9% since, to $1,535 in 2025. Among physician assistant clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $217.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$34K
- Johnson & Johnson$493
- Pfizer$255
- AbbVie$222
- Novartis$193
- Incyte Corporation$160
- plus $824 from 15 others
What the payments were for
- Speaking & faculty fees$28,09077%
- Travel & lodging$3,95111%
- Food & beverage$3,97111%
- Education$4441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 83 | $34,308 |
| Johnson & Johnson | 20 | $493 |
| Pfizer | 13 | $255 |
| AbbVie | 14 | $222 |
| Novartis | 9 | $193 |
| Incyte Corporation | 3 | $160 |
| Sun Pharmaceutical Industries Inc. | 3 | $158 |
| Organogenesis Inc. | 2 | $143 |
| Prugen, Inc. Pharmaceuticals | 1 | $140 |
| Amgen | 5 | $94 |
| Boehringer Ingelheim | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| VYNE Pharmaceuticals Inc. | 1 | $46 |
| Lilly USA, LLC | 2 | $31 |
| UCB, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Sanofi | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Almirall LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,456 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 26 | $100,460 |
| Cosentyx (2 Syringes)Secukinumab | 12 | $86,575 |
| Dupixent SyringeDupilumab | 13 | $47,594 |
| Clobetasol Propionate | 136 | $10,859 |
| Ketoconazole | 438 | $9,049 |
| Fluorouracil | 47 | $3,958 |
| Mupirocin | 396 | $3,388 |
| Mometasone Furoate | 99 | $2,395 |
| Triamcinolone Acetonide | 139 | $1,684 |
| Acitretin | 13 | $1,572 |
| Doxycycline Hyclate | 109 | $1,200 |
| Clindamycin Phosphate | 26 | $1,198 |
| Metronidazole | 15 | $773 |
| ValacyclovirValacyclovir Hcl | 28 | $420 |
| Cephalexin | 122 | $322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisCosentyx (2 Syringes) | $193 | $86,57512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Manchester
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$187K
- Katherine RunyanKnoxville$156K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- John KramerNashville$109K
- Whitney GatewoodMemphis$104K
- Nicholas BarkemeyerNashville$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.